Laquinimod, an oral quinolone-3-carboxamide, was shown to slow the progression of disability and reduce rates of relapse in patients with relapsing-remitting multiple sclerosis (RRMS), according to results of a recent phase 3 study [N Engl J...
Laquinimod, an oral quinolone-3-carboxamide, was shown to slow the progression of disability and reduce rates of relapse in patients with relapsing-remitting multiple sclerosis (RRMS), according to results of a recent phase 3 study [N Engl J...
Laquinimod, an oral...